Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1123-1130

  Doong, Ming Luen ^a   Lu, Chien Chen ^a   Kau, Mei Mei ^a   Tsai, Shiow Chwen ^a   Chiao, Yu Chung ^a   Chen, Jiann Jong ^a   Yeh, Jiun Yih ^a   Lin, Ho ^a   Huang, Seng Wong ^b   Chen, Tseng Shing ^a   Chang, Full Young ^a   Wang, Paulus S ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Amphetamine; Cholecystokinin (CCK); Gastric emptying; Gastrointestinal (GI) transit; Geometric centre; Lorglumide; PD 135,158; Proglumide

Indexed keywords

AMPHETAMINE; ANOREXIGENIC AGENT; CHOLECYSTOKININ; LORGLUMIDE; PD 135158; PROGLUMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; INTESTINE TRANSIT TIME; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING;

AMPHETAMINES; ANIMALS; CHOLECYSTOKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HORMONE ANTAGONISTS; INDOLES; MALE; MEGLUMINE; PROGLUMIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 14444276529     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701937     Document Type: Article

References (53)

1. ANIKA, M.S. (1982). Effects of cholecystokinin and caerulein on gastric emptying. Eur. J. Pharmacol., 85, 195-199.
2. BALLINGER, A.B. & CLARK, M.L. (1994). L-Phenylalanine releases cholecystokinin (CCK) and is associated with reduced food intake in humans: evidence for physiological role of CCK in control of eating. Metabolism, 43, 735-738.
3. BAZE, L. (1974). A role of catecholamines in the anorexic effects of amphetamine in rats. Psychopharmacologia, 35, 91-98.
4. BEGLINGER, C. (1994). Effect of cholecystokinin on gastric motility in humans. Ann. New York Acad. Sci., 713, 219-225.
5. BOOTH, D.A. (1968). Amphetamine anorexia by direct action on the adrenergic feeding system of rat hypothalamus. Nature, 217, 869-870.
6. BRAY, G.A. (1993). Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann. Intern. Med., 119, 707-713.
7. BRIDGES, J.W., DENT, J.G. & JOHNSON, P. (1975). The effects of some pharmacologically active amines on the rate of gastric emptying in rats. Life Sci., 18, 97-108.
8. CHEN, T.S., DOONG, M.L., WANG, S.W., TSAI, S.C., LU, C.C., SHIH, H.C., CHEN, Y.H., CHANG, F.Y., LEE, S.D. & WANG, P.S. (1997). Gastric emptying and gastrointestinal transit during lactation in rats. Am. J. Physiol., 272, G626-G631.
9. CHEY, W.Y., HITANANT, S., HENDRICKS, J. & LORBER, S.H. (1970). Effect of secretin and cholecystokinin on gastric emptying and gastric output in man. Gastroenterology, 58, 820-827.
10. COLE, S.O. (1978). Brain mechanisms of amphetamine-induced anorexia, locomotion, and stereotypy: a review. Neurosci. Biobehav. Rev., 2, 89-100.
11. COLTON, N.H., SEGAL, H.I., STEINBERG, A., SHECHTER, F.R. & PASTOR, N. (1943). The management of obesity with emphasis on appetite control. Am. J. Med. Sci., 206, 75-86.
12. DAVIES, R.F., ROSSI III, J., PANKSEPP, J., BEAN, N.J. & ZOLOVICK, A.J. (1983). Fenfluramine anorexia: A peripheral locus of action. Physiol. Behav., 30, 723-730.
13. DEBAS, H.T., FAROOQ, O. & GROSSMAN, M.I. (1975). Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology, 68, 1211-1217.
14. DEUTSCH, J.A. (1983). Dietary control and stomach. Prog. Neurobiol., 20, 313-332.
15. FEINLE, C., D'AMATO, M. & READ, N.W. (1996). Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology, 110, 1379-1385.
16. FIORAMONTI, J., FARGEAS, M.J., BERTRAND, V., PRADAYROL, L. & BUENO, L. (1994). Induction of postprandial intestinal motility and release of cholecystokinin by polyamines in rats. Am. J. Physiol., 267, G960-G965.
17. GARDNER, J.D. & JENSEN, R.T. (1984). Cholecystokinin receptor antagonists. Am. J. Physiol., 246, G471-G476.
18. GIBBS, J. FALASCO, J.D. & MCHUGH, P.R. (1976). CCK-decreased food intake in rhesus monkeys. Am. J. Physiol., 230, 15-18.
19. GIBBS, J., YOUNG, R.C. & SMITH, G.P. (1973). Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol., 84, 488-495.
20. HABA, T. & SARNA, S.K. (1993). Regulation of gastroduodenal emptying of solids by gastropyloroduodenal contractions. Am. J. Physiol., 264, G261-G271.
21. HAHNE, W. H., JENSEN, R.T., LEMP, G.F. & GARDNER, J.D. (1981). Proglumide and benzotript: members of a new class of cholecystokinin antagonists. Proc. Natl. Acad. Sci. U.S.A., 78, 6304-6308.
22. HARRIS, S.C., IVY, A.C. & SEARLE, L.M. (1947). The mechanisms of amphetamine-induced weight loss. J. Am. Med. Assoc., 134, 1468-1475.
23. HOLZER, P. (1985). Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br. J. Pharmacol., 86, 305-312.
24. HUGUES, J., BODEN, P., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6732.
25. HULL, K.M., ZANZILLARI, R. & MATHER, T.J. (1993). Comparison between phenylpropanolamine and structurally related compounds on gastric transit in the rat. Pharmacol. Biochem. Behav., 46, 411-414.
26. HWU, C.M., TSAI, S.M., LAU, C.P., PU, H.F., WANG, T.L., CHIANG, S.T. & WANG, P.S. (1992). Increased concentrations of atrial and plasma atrial natriuretic peptide in castrated male rats. Life Sci., 52, 205-212.
27. INNIS, R.B. & SYNDER, S.H. (1980). Distinct cholecystokinin receptors in brain and pancrease. Proc. Natl. Acad. Sci. U.S.A., 77, 6917-6921.
28. JIN, H.O., LEE, K.Y., CHANG, T.M., CHEY, W.Y. & DUBOIS, A. (1994). Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Dig. Dis. Sci., 39, 2306-2314.
29. JOHNSON, L.R. (1991). Gastrointestinal Physiology. 4th Ed. St Louis: Mosby-Year Book, Inc.
30. KATSCHINSKI, M., SCHIRRA, J., BEGLINER, C., LANGBEIN, S., WANK, U., D'AMATO, M. & ARNOLD, R. (1996). Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. Eur. J. Clin. Invest., 26, 574-583.
31. KOPIN, A.S., LEE, Y.M., MCBRIDE, E.W., MILLER, L.J., LU, M., LIN, H.Y., KOLAKOWSKI, L.F. & BEINBORN, M. (1992). Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 3605-3609.
32. LEIBOWITZ, S.F. (1975). Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia. Brain Res., 98, 529-545.
33. MAKOVEC, F., BANI, M., CHISTE, R., REVEL, L., ROVATI, L.C. & SETNIKAR, L. (1986). Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats. Regul. Pept., 16, 281-290.
34. MANGEL, A.W. & KOEGEL, A. (1984). Effects of peptides on gastric emptying. Am. J. Physiol., 246, G342-G345.
35. MARGOLIS, R.L., MORAN, T.H. & MCHUGH, P.R. (1989). In vitro response of rat gastrointestinal segments to cholecystokinin and bombesin. Peptides, 10, 157-161.
36. MILLER, M.S., GALLIGAN, J.J. & BURKS, T.F. (1981). Accurate measurement of intestinal transit in the rat. J. Pharmacol. Meth., 6, 211-217.
37. MONSTEIN, H.J., NYLANDER, A.G., SALEHI, A., CHEN, D., LUNDQUIST, I. & HÅKANSON, R. (1996). Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of rat and man. A polymerase chain reaction study. Scand. J. Gastroenterol., 31, 383-390.
38. MORAN, T.H., KORNBLUH, R., MOORE, K. & SCHWARTZ, G.J. (1994). Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites. Regul. Pept., 52, 165-172.
39. MORAN, T.H. & MCHUGH, P.R. (1982). Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol., 242, R491-R497.
40. MORAN, T.H., ROBINSON, P.H., GOLDRICH, M.S. & MCHUGH, P.R. (1986). Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res., 362, 175-179.
41. MURPHY, R.B., SMITH, G.P. & GIBBS, J. (1987). Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus. Peptides, 8, 127-134.
42. PISEGNA, J.R., DE WEERTH, A., HUPPI, K. & WANK, S.A. (1992). Molecular cloning of human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem. Biophys. Res. Commun., 189, 296-303.
43. PURDON, R.A. & BASS, P. (1973). Gastric and intestinal transit in rats measured by a radioactive test meal. Gastroenterology, 64, 968-976.
44. RODRIGUEZ-MEMBRILLA, A. & VERGARA, P. (1997). Endogenous CCK disrupts the MMC pattern via capsaicin-sensitive vagal afferent libers in the rat. Am. J. Physiol., 272, G100-G105.
45. SILVENTE-POIROT, S., DUFRESNE, M., VAYSSE, N. & FOURMY, D. (1993). The peripheral cholecystokinin receptors. Eur. J. Biochem., 215, 513-529.
46. STEEL, R.D. & TORRIE, J.H. (1960). Principles and Procedures of Statistics. New York: McGraw-Hill.
47. TAINTER, M.L. (1944). Actions of benzedrine and propadrine in the control of obesity. J. Nutr., 27, 90-105.
48. VARGA, G. & SCARPIGNATO, C. (1996). Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists. Eur. J. Pharmacol., 306, 153-159.
49. VANLIERE, E.J. & SLEETH, C.K. (1939). The effect of benzedrine sulfate on the emptying time of human stomach. J. Pharmacol. Exp. Ther., 62, 111-115.
50. WANK, S.A., PISEGNA, J.R. & DE WEERTH, A. (1992). Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc. Natl. Acad. Sci. U.S.A., 89, 8691-8695.
51. WELLMAN, P.J. (1990a). A review of the physiological bases of anorexia action of phenylpropanolamine (d,l-norephedrine). Neurosci. Biobehav. Rev., 14, 339-355.
52. WELLMAN, P.J. (1990b). Effects of haloperidol on anorexia induced hy l-norephedrine and d-amphetamine in adult rats. Pharmacol. Biochem. Behav., 35, 457-460.
53. WELLMAN, P.J & PETERS, R.H. (1980). Effects of amphetamine and phenylpropanolamine on food intake in rats with ventromedial hypothalamic or dorsolaleral tegmental damage. Physiol. Behav., 25, 819-827.